We welcome organizations, institutions, vendors and industry involvement.
Contact us to add your logo or to become a Partner or Patron.
2023 Lead Partner
CSID is a disorder that reduces the effectiveness of enzymes that digest carbohydrates (sugar and starch). Congenital Sucrase-Isomaltase Deficiency, also known as Genetic Sucrase-Isomaltase Deficiency (GSID), is an inherited disorder that causes these digestive enzymes either to be missing or to not work as well. Sucraid® is the only FDA-approved enzyme replacement therapy for the treatment of CSID.